Olix Pharmaceuticals, Inc.

Olix Pharmaceuticals, Inc. company information, Employees & Contact Information

Accelerating Drug Development using Oligonucleotides Since its discovery, RNA interference (RNAi) technology has been widely recognized as a novel drug development platform that could change the paradigm of therapeutic development. OliX Pharmaceuticals is a clinical stage pharmaceutical company developing therapeutics based on the science of RNAi to address a wide variety of illnesses. The Company has developed core platforms (asymmetric siRNA, cell-penetrating asiRNA) targeting locally administrable diseases, such as hypertrophic scars, hair loss, and age-related macular degeneration (AMD). OliX's third RNAi therapeutic platform, GalNAc-asiRNA, targets multiple liver diseases, including NASH/diabetes and HBV. For the general welfare of human beings, OliX is constantly endeavoring to become a leader in the global biotechnology industry by innovating and expanding its pipeline, even to the undruggable diseases.

Company Details

Employees
48
Founded
-
Address
Ace Gwanggyo Tower1, Suite 1014, 17,daehak 4-Ro,yeongtong-Gu,korea, Republic Of
Phone
+82-031-779-8400
Email
ol****@****rma.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Suwon-si, Gyeonggi-do
Looking for a particular Olix Pharmaceuticals, Inc. employee's phone or email?

Olix Pharmaceuticals, Inc. Questions

News

OliX and Lilly Enter Global Licensing Agreement for MASH and Other Cardiometabolic Indications - Business Wire

OliX and Lilly Enter Global Licensing Agreement for MASH and Other Cardiometabolic Indications Business Wire

Driving drug development through next-generation oligonucleotide technology - Nature

Driving drug development through next-generation oligonucleotide technology Nature

OliX Pharmaceuticals Receives HREC Approval to Initiate Phase 1 Clinical Trial of NASH and Obesity Drug - The AI Journal

OliX Pharmaceuticals Receives HREC Approval to Initiate Phase 1 Clinical Trial of NASH and Obesity Drug The AI Journal

Hansoh Pharma and OliX Pharmaceuticals Enter into Licensing - GlobeNewswire

Hansoh Pharma and OliX Pharmaceuticals Enter into Licensing GlobeNewswire

OliX Pharmaceuticals Inks MOU with DynamiCure Biotechnology to Develop ADC Immunotherapy Using RNA at Korea-US Digital·BioHealth Business Forum - Business Wire

OliX Pharmaceuticals Inks MOU with DynamiCure Biotechnology to Develop ADC Immunotherapy Using RNA at Korea-US Digital·BioHealth Business Forum Business Wire

OliX Pharmaceuticals Announces Results from Preclinical Study of Hair Loss Therapeutic Candidate - Yahoo Finance

OliX Pharmaceuticals Announces Results from Preclinical Study of Hair Loss Therapeutic Candidate Yahoo Finance

OliX Pharmaceuticals Publishes Preclinical Research Demonstrating OLX104C’s Potential as an Effective Treatment for Hair Loss - Business Wire

OliX Pharmaceuticals Publishes Preclinical Research Demonstrating OLX104C’s Potential as an Effective Treatment for Hair Loss Business Wire

OliX Pharmaceuticals Announces Positive Results from a Phase 2a Trial of OLX10010 for Hypertrophic Scar Treatment - Business Wire

OliX Pharmaceuticals Announces Positive Results from a Phase 2a Trial of OLX10010 for Hypertrophic Scar Treatment Business Wire

OliX Pharmaceuticals Administers First Patient in Phase 1 Clinical Study of RNAi Therapeutic OLX72021 for Androgenic Alopecia - Business Wire

OliX Pharmaceuticals Administers First Patient in Phase 1 Clinical Study of RNAi Therapeutic OLX72021 for Androgenic Alopecia Business Wire

Top Olix Pharmaceuticals, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant